Risk factor
Very poor trading liquidity
Profitability factor
Decent dividends
About
A-SPINE Asia Co., Ltd. functions as a medical device enterprise, specializing in the entire cycle of research, development, production, and worldwide distribution of spinal implants and surgical instruments. The company's market presence spans numerous countries, including Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. Their product catalog features a variety of spinal stabilization systems, such as solutions for cervical anterior fixation, alongside thoracic and lumbar fixation devices. Additionally, A-SPINE Asia provides a comprehensive range of interbody fusion systems, encompassing ACDF, PLIF, TLIF, and ALIF cages. Its offerings further extend to balloon kyphoplasty and vertebral body replacement devices. Beyond its own manufactured products, the firm also acts as a distributor for a selection of imported orthopedic medical equipment. Established in 2001, A-SPINE Asia Co., Ltd. is based in New Taipei City, Taiwan.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EB